The Pathogenesis of Adenomyosis

In: Adenomyosis · 2021 · pp. 5–19 · doi:10.1007/978-981-33-4095-4_2 · W3131534324
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-07

This chapter will review and focus on the latest knowledge regarding the pathogenesis of adenomyosis, a benign gynecological disease where endometrial tissue invades the myometrium.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This chapter reviews adenomyosis, a benign, estrogen-dependent disease in which endometrial glands and stroma invade the myometrium, discussing its clinical features and the increasing detection rates enabled by MRI and transvaginal ultrasound. It synthesizes current knowledge on mechanisms underlying adenomyosis pathogenesis, while noting that its true pathogenesis remains unclear despite the disease being described for nearly 100 years. A key limitation is that this is a narrative overview rather than a study with original data or a specific systematic assessment of evidence quality. Relevance to endometriosis: the chapter explicitly states that adenomyosis often combines with endometriosis and cites proposed shared concepts such as tissue injury and repair (TIAR) and an association/revisiting mechanisms between adenomyosis and endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 9,848 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Adenomyosis refers to an estrogen-dependent gynecological benign disease in which the endometrial glands and stroma invade the myometrium, resulting in localized or diffuse adenomyosis. It often combines with uterine fibroids, endometrial polyps, endometriosis, etc. The incidence of adenomyosis ranges from 1 to 70% [1] due to the variation of diagnostic criteria. The main clinical manifestations are progressive dysmenorrhea, chronic pelvic pain, menorrhagia, and infertility. With the improvement of magnetic resonance imaging (MRI), transvaginal ultrasound imaging, and other examination techniques, the detection rate of adenomyosis is also increasing [2, 3]. Although it has been nearly 100 years since the name of the disease is mentioned, the true pathogenesis of adenomyosis is still a mystery. This chapter will discuss and focus on the latest knowledge in the pathogenesis of adenomyosis. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Graziano A, et al. Diagnostic findings in adenomyosis: a pictorial review on the major concerns. Eur Rev Med Pharmacol Sci. 2015;19(7):1146–54. Tellum T, et al. Development of a clinical prediction model for diagnosing adenomyosis. Fertil Steril. 2018;110(5):957–964.e3. Karamanidis D, et al. OC01: Transvaginal ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis. Ultrasound Obstet Gynecol. 2018;52(4):555. Scoutt LM, et al. Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology. 1991;179(2):403–7. Agostinho L, et al. MRI for adenomyosis: a pictorial review. Insights Imaging. 2017;8(6):549–56. Riggs JC, et al. Cesarean section as a risk factor for the development of adenomyosis uteri. J Reprod Med. 2014;59(1–2):20–4. Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Invest. 2011;5(2):125–42. Li T, Li Y-G, Pu D-M. Matrix metalloproteinase-2 and-9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Investig. 2006;62(4):229–35. Xiao Y, et al. Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):419–22. Hricak H, et al. Magnetic resonance imaging of the female pelvis: initial experience. Am J Roentgenol. 1983;141(6):1119–28. Yifu S. There are some questions about uterine adenopathy. China Fam Plan Obstet Gynecol. 2018;10(1):3–6. Leyendecker G, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291(4):917–32. Shaked S, et al. Uterine peristalsis-induced stresses within the uterine wall may sprout adenomyosis. Biomech Model Mechanobiol. 2015;14(3):437–44. Uduwela A, et al. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv. 2000;55(6):390–400. Liu Jingjing DH. Wangsha the expression and significance of nitric oxide in the smooth muscle cells in the endometrial-myoline junction region of uterine adenopathic patients. Chinese J Obstet Gynecol. 2013;48(007):504–7. Kyo S, et al. Telomerase activity in gynecological tumors. Clin Cancer Res. 1996;2(12):2023–8. Xue Q, Zhou Y, Liu Y. Expression of ki67 and CA_ (125) in Adenomyosis. J Pract Obstet Gynecol. 2003;5 Deng Y, Chunlan H, Xiaoling L. Expression of Survivin in Adenomyosis and its relationship with Bcl-2 and Bax protein. J Med Res. 2006;6 Xiao Y, et al. Expression of integrin beta3 and osteopontin in endometrium of patients with adenomyosis. Zhonghua Fu Chan Ke Za Zhi. 2009;44(5):354–8. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265–73. Acloque H, et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–49. An M, et al. Interaction of macrophages and endometrial cells induces epithelial–mesenchymal transition-like processes in adenomyosis. Biol Reprod. 2017;96(1):46–57. Khan KN, et al. Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod. 2015;92(2):35. 1-11 Oh SJ, et al. β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial–mesenchymal transition. J Pathol. 2013;231(2):210–22. Chen YJ, et al. Oestrogen-induced epithelial–mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol. 2010;222(3):261–70. Sobel V, Zhu Y-S, Imperato-McGinley J. Fetal hormones and sexual differentiation. Obstet Gynecol Clin. 2004;31(4):837–56. Spencer TE, et al. Comparative developmental biology of the mammalian uterus. Curr Top Dev Biol. 2005;68:85–122. Donnez J, et al. Stereometric evaluation of peritoneal endometriosis and endometriotic nodules of the rectovaginal septum. Hum Reprod. 1996;11(1):224–8. Enatsu A, et al. Adenomyosis in a patient with the Rokitansky-Kuster-Hauser syndrome. Fertil Steril. 2000;73(4):862–3. Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update. 2007;13(1):87–101. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod. 2004;70(6):1738–50. Kato K. Stem cells in human normal endometrium and endometrial cancer cells: characterization of side population cells. Kaohsiung J Med Sci. 2012;28(2):63–71. Long Wenjie GL, Fudi L, Xin S, Hui L. Stem cells and their relationship with adenomyosis*. Prog Mod Biomed. 2017;17(2):393–5. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81–5. Zhang W-B, et al. A study in vitro on differentiation of bone marrow mesenchymal stem cells into endometrial epithelial cells in mice. Eur J Obstet Gynecol Reprod Biol. 2012;160(2):185–90. Morelli SS, Rameshwar P, Goldsmith LT. Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod. 2013;89(1):1–7. Du H, Naqvi H, Taylor HS. Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev. 2012;21(18):3324–31. Ibrahim MG, et al. Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis. Fertil Steril. 2015;104(6):1475–1483.e3. Zhang Yumin ZS. The study of pale cells and adenomyosis. Chin J Obstet Gynecol. 2018;1:39. Zhang X, et al. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril. 2009;92(5):1799–801. Choi YS, et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis. Growth Factors. 2010;28(6):452–60. Ota H, Tanaka T. Stromal vascularization in the endometrium during adenomyosis. Microsc Res Tech. 2003;60(4):445–9. Mu Y, et al. Serum levels of vascular endothelial growth factor and cancer antigen 125 are related to the prognosis of adenomyosis patients after interventional therapy. Int J Clin Exp Med. 2015;8(6):9549. Liu X, et al. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31(4):734–49. Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18(4):428–37. Ota H, et al. Is adenomyosis an immune disease? Hum Reprod Update. 1998;4(4):360–7. Garavaglia E, et al. Adenomyosis and its impact on women fertility. Iran J Reprod Med. 2015;13(6):327. Vannuccini S, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. Liu Y, et al. Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients. Current Res Transl Med. 2016;64(3):123–8. Ye F, Zhang J, Qin J-q. Expression and significance of COX-2 and VEGF in adenomyosis. J Harbin Med Univ. 2006;3 Huang Y, et al. Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis. Arch Gynecol Obstet. 2011;283(4):775–80. Cakmak H, et al. Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed). 2009;1(2):429–43. Keenan JA, et al. Interferon-gamma (IFN-γ) and Interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned Media of Women with Endometriosis. Am J Reprod Immunol. 1994;32(3):180–3. Bergqvist A, et al. Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium. Fertil Steril. 2001;75(3):489–95. Yang JH, et al. Increased interleukin-6 messenger RNA expression in macrophage-cocultured endometrial stromal cells in adenomyosis. Am J Reprod Immunol. 2006;55(3):181–7. Chen C, et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun. 2017;8(1):1–11. Author information Authors and Affiliations Editor information Editors and Affiliations Rights and permissions Copyright information © 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. About this chapter Cite this chapter Xiao, F. (2021). The Pathogenesis of Adenomyosis. In: Xue, M., Leng, J., Wong, F. (eds) Adenomyosis. Springer, Singapore. https://doi.org/10.1007/978-981-33-4095-4_2 Download citation DOI: https://doi.org/10.1007/978-981-33-4095-4_2 Published: Publisher Name: Springer, Singapore Print ISBN: 978-981-33-4094-7 Online ISBN: 978-981-33-4095-4 eBook Packages: MedicineMedicine (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (55)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK